期刊文献+

重组人脑利钠肽对大鼠心肌梗死后心功能的影响 被引量:10

EFFECTS OF RHBNP ON CARDIAC FUNCTION AFTER ACUTE MYOCARDIAL INFARCTION
下载PDF
导出
摘要 [目的]探讨重组人脑利钠肽(rhBNP)连续给药4周对心肌梗死后大鼠心功能的影响。[方法]制急性心肌梗死(AMI)模型雄性SD大鼠45只,随机分AMI对照组、小剂量rhBNP治疗组、大剂量rhBNP治疗组,各设15只。另设15只作假手术组。rhBNP治疗组经颈静脉输液管输注rhBNP,剂量为15μg/kg,每日1次,持续4周,假手术组及AMI对照组仅以等体积的生理盐水输注。4周后检测血流动力学参数。[结果]与假手术组比较,AMI对照组收缩压(SBP)、舒张压(DBP)、左室收缩压(LVSP)及左室内压最大上升和下降速率(±dp/dt)均明显降低(P均﹤0.01);左室舒张末压(LVEDP)明显升高(P﹤0.01)。与AMI对照组比较,rhBNP治疗组SBP、DBP、LVSP及±dp/dt均明显升高(P均﹤0.01);LVEDP均明显降低(P﹤0.01)。[结论]外源性的重组人脑利钠肽连续应用能改善AMI大鼠血流动血参数,保护心功能。 [Objective] To assess the effects of long-term infusion of recombinant human brain natriuretie peptide (rhBNP) on cardiac function after acute myocardial infarction (AMI) in ratS. [ Methods] Forty-five male Sprague Dawley rats surviving AMI, which was achieved by ligating coronary artery, were randomized to AMI control group (15) or rhBNP treatment group ( 15 ). Fifteen sham-operated Sprague Dawley rats were selected to serve as non-infarction controls. Two days after surgery, intravenous infusion of rhBNP Or saline (for AMI control and sham-operated groups) was started through jugular vein. After 4 weeks treatment, hemodynamic measurement was performed. [ Results] Comparing with sham-operated rats, SBP, DBP, the left ventricular systolic pressure (LVSP) and the maximum rising and dropping rates of left ventrieular pressure (± dp/ dt) in AMI control group were significandy reduced (all P 〈 0.01) , while the left ventricular end diastolic pressure (LVEDP), in AMI control group were significantly increased (all P 〈 0.01 ). In contract, comparing with AMI control group, SBP, DBP, LVSP and ±dp/dt in rhBNP treatment group was significandy increased (all P 〈 0,01), while LVEDP in rhBNP treatment group was significantly reduced (P 〈 0.01 ). [Conclusion] RhBNP is effective in improving cardiac function after AMI in rats.
出处 《现代预防医学》 CAS 北大核心 2008年第17期3449-3451,共3页 Modern Preventive Medicine
关键词 重组人脑利钠肽(rhBNP) 血流动力学 心功能 心肌梗塞 疾病模型 动物 大鼠 RhBNP Hemodynamics Cardiac function Myocardial infarction Disease models Animal Rats
  • 相关文献

参考文献20

  • 1Oliver P, Fox J, Kim R, et al. Hypertension, cardiac hypertrophy and sudden death in mice lacking natriuretie peptide receptor A[J]. Proc Natl Acad Sci USA, 1997, 94: 14730-14735.
  • 2Tanmra N, Ogawa Y, Chusho H, et al. Cardiac fibrosis in mice lacking brain natriuretic peptide [J]. Proc Natl Acad Sci USA, 2000, 97:4239-4244.
  • 3Ellmers L, Knowles J, et al. Ventricular expression of atrial and brain natriuretie peptide in NPR-1 deficient mice with cardiac hypertrophy and fibrosis [J]. Am J Physiol, 2002, 283: H707- H714.
  • 4Vicky AC, Leigh J. Minireview: Natriuretie peptides during development of the fetal heart and circulation[J]. Endocrinology, 2003, 144 (6): 2191-2194.
  • 5Surakit Nathisuwan, Robert L. Talbert. A Review of Vasopeptidase lnhibitors: A New Modality in the Treatment of Hypertension and Chronic Heart Failure[J].Pharmacotherapy, 2002, 22 (1): 27- 42.
  • 6Miriam TR, Richard AM. Cardiac natriuretic peptides for cardiac heahh [J]. Clinical Science, 2005, 108: 23-36.
  • 7Osman, R, Alat I, Coskun S, et al. The Role of Brain Natriuretic Peptide in the prediction of Cardiac Performance in Coronary Artery Bypass Grafting [J]. Tex. Heart Inst. J, 2003, 30: 298-304.
  • 8Fujisaki H, lto H, Hirata Y, et al. Natriuretic Peptides Inhibit Angiotensin Ⅱ -induced Proliferation of Rat Cardiac l:ibroblasts by Blocking Endothelin-1 Gene Expression [J]. J. Clin. Invest, 1995, 96: 1059-1065.
  • 9Michaels AD, Klein A, Madden JA, et al. Effects of Intravenous Nesiritide on Human Coronary Vasomotor Regulation and Myocardial Oxygen Uptake [J]. Circulation, 2003, 107: 2697.
  • 10Souzal SPD, YeUon DM, Martin C et al. B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening [J]. Am J Physiol Heart Circ Physiol, 2003, 284: H1592- H1600.

二级参考文献51

  • 1张辉,赵旭兰,郝玉明,王建华,李建华,乔丽敏,谢文丽.急性心肌梗死早期应用不同剂量AT_1受体拮抗剂对左室重构的临床研究[J].中国全科医学,2005,8(13):1058-1060. 被引量:4
  • 2蔚永运,傅向华,刘君,谷新顺,吴伟力,李世强,范卫泽,姜云发.冠状动脉内注射山莨菪碱对急性心肌梗死介入治疗后缓再血流现象的作用[J].临床心血管病杂志,2006,22(1):21-24. 被引量:22
  • 3陈国伟.2005年美国化学委员会/心脏协会心力衰竭治疗指南浅析及血管紧张素Ⅱ受体阻滞剂在心力衰竭治疗中的地位[J].中国全科医学,2006,9(22):1905-1906. 被引量:6
  • 4Cao L, Gardner DG. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension, 1995,25:227-234.
  • 5Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail, 1998,4:37-44.
  • 6Mills RM, LeJemtel TH, Horton DP, et al. Sustained hemodynamic effects of an infusion of nesiritide ( human B-type natriuretic peptide)in heart failure: a randomized, double-blind, placebo-controlled clinical trial Natrecor Study Group. J Am Coil Cardiol, 1999,34:155-162.
  • 7Silver MA, Horton DP, Ghali JK, et aL Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol, 2002,39 :798-803.
  • 8Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide,a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Meal, 2000,343:246-253.
  • 9Emerman CL Safety and efficacy of nesiritide for the treatment of decompensated heart failure. Bey Cardiovasc Med, 2002,3 Suppl 4 :S28 -S34.
  • 10Peacock WF, Emerman CE, Doleh M, et al. The incidence of non-ST segment elevation MI in emergency department patients presenting with decompensated heart failure. Congest Heart Fail, 2003,9:303-308.

共引文献346

同被引文献77

引证文献10

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部